Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 3
2014 9
2015 19
2016 28
2017 65
2018 110
2019 148
2020 213
2021 270
2022 321
2023 332
2024 352
2025 469
2026 250

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,308 results

Results by year

Filters applied: . Clear all
Page 1
Microneedle-mediated drug delivery for Parkinson's disease: advances, challenges, and future perspectives.
Gandhi SM, Tyagi A, Shukla S, Haswani NG, Wahab S, Alshehri SA, Kapoor DU. Gandhi SM, et al. J Biomater Sci Polym Ed. 2026 Jun 12:1-31. doi: 10.1080/09205063.2026.2683530. Online ahead of print. J Biomater Sci Polym Ed. 2026. PMID: 42283118 Review.
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder worldwide, affecting over 8.5 million individuals, with prevalence projected to exceed 12 million by 2040 due to global population aging. ...Despite remaining challenges in scala …
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder worldwide, affecting over 8.5 million …
The Role of Serotonergic System in Parkinson's Disease-Related Pain.
Song YZ, Shen YQ. Song YZ, et al. Neurosci Bull. 2026 Jun 11. doi: 10.1007/s12264-026-01649-8. Online ahead of print. Neurosci Bull. 2026. PMID: 42274907 Review.
Pain affects up to 85% of Parkinson's disease (PD) patients, but treatment options remain limited. The brainstem serotonergic raphe nuclei, as the main source of central serotonin, dysfunction early in PD. ...
Pain affects up to 85% of Parkinson's disease (PD) patients, but treatment options remain limited. The brainstem seroto …
Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment.
Damiens Q, Mille V, Faure J, Toussirot E, Valnet-Rabier MB, Béreau M. Damiens Q, et al. J Parkinsons Dis. 2026 Jun 10:1877718X261432743. doi: 10.1177/1877718X261432743. Online ahead of print. J Parkinsons Dis. 2026. PMID: 42268283 Free article. Review.
Gastroparesis (GP), defined as delayed gastric emptying (GE) without mechanical obstruction, is an underdiagnosed non-motor symptom of Parkinson's disease (PD) that may affect levodopa pharmacokinetics and contribute to motor fluctuations. In PD, GP pathophys …
Gastroparesis (GP), defined as delayed gastric emptying (GE) without mechanical obstruction, is an underdiagnosed non-motor symptom of Pa …
Harnessing the Ocean's Power: Fucoidan as a Novel Neuroregenerative Agent.
Wu Q, Hui X, Cui A, Meng X. Wu Q, et al. Drug Dev Res. 2026 Jun;87(4):e70331. doi: 10.1002/ddr.70331. Drug Dev Res. 2026. PMID: 42266137 Review.
Neurological disorders, characterized by progressive neuronal loss and functional decline, pose a formidable challenge to global health due to the lack of effective therapies. ...By consolidating findings from diverse preclinical models of ischemic stroke, traumatic brain …
Neurological disorders, characterized by progressive neuronal loss and functional decline, pose a formidable challenge to global heal …
Synthetic microbial communities: a novel emerging models for dissecting gut microbiota-host interactions in neurodegenerative diseases.
Feng P, Zhang W, Zhao Y, Zhao P, Li E. Feng P, et al. Front Immunol. 2026 May 21;17:1822743. doi: 10.3389/fimmu.2026.1822743. eCollection 2026. Front Immunol. 2026. PMID: 42253968 Free PMC article. Review.
The gut-brain axis (GBA) has emerged as a critical regulatory pathway underlying the pathogenesis of neurodegenerative diseases (NDs) such as Alzheimer's disease and Parkinson's disease. However, the high complexity and individual variability of native …
The gut-brain axis (GBA) has emerged as a critical regulatory pathway underlying the pathogenesis of neurodegenerative diseases (NDs) such a …
AS-IV attenuates nigral NLRP3 inflammasome in a Parkinson's disease mouse model via gut microbiota.
Cai J, Wang M, You Y, Sun F, Wang M, Wang N, Wang R, Zhang K, Ge R, Wang H. Cai J, et al. Commun Biol. 2026 Jun 6. doi: 10.1038/s42003-026-10415-5. Online ahead of print. Commun Biol. 2026. PMID: 42251131 Free article.
Astragaloside IV (AS-IV) neuroprotection against rotenone (ROT)-induced Parkinson's pathology was examined via microbiota-gut-brain axis mechanisms. Methods included intraperitoneal AS-IV, fecal microbiota transplantation (FMT) from AS-IV-treated mice, …
Astragaloside IV (AS-IV) neuroprotection against rotenone (ROT)-induced Parkinson's pathology was examined via microbiota …
Periodontal health in a longitudinal French cohort of people with Parkinson's disease.
Samot J, Courtin E, Guehl D, Damon-Perriere N, Branchard O, Saint-Jean M, Chuy V, Ella B, Badet MC. Samot J, et al. Sci Rep. 2026 Jun 5. doi: 10.1038/s41598-026-55641-3. Online ahead of print. Sci Rep. 2026. PMID: 42249009 Free article.
Motor impairment associated with Parkinson's disease (PD) can hinder daily oral hygiene. This study aimed to assess the microbiological and clinical evolution of periodontal health in people with PD. ...
Motor impairment associated with Parkinson's disease (PD) can hinder daily oral hygiene. This study aimed to assess the …
The microbiota-tryptophan-brain axis in neurodegenerative diseases: pathogenic mechanisms, disease-specific roles, and translational therapeutics.
Wang Z, Li L, Dong Y, Zhang Y. Wang Z, et al. Front Microbiol. 2026 May 20;17:1820111. doi: 10.3389/fmicb.2026.1820111. eCollection 2026. Front Microbiol. 2026. PMID: 42245509 Free PMC article. Review.
The pathogenesis of neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD) and Parkinson's disease (PD) is very complex. Recent studies have shown that gut microbiota and their metabolites play a key role in the progression of these …
The pathogenesis of neurodegenerative diseases (NDDs) such as Alzheimer's disease (AD) and Parkinson's disease ( …
The NLRP3-alpha-Synuclein Circuit: A Core Driver and Therapeutic Target in Parkinson's Disease.
Liu K, He Z, Zhang L, Wu YM, Xiao L. Liu K, et al. J Inflamm Res. 2026 May 28;19:597280. doi: 10.2147/JIR.S597280. eCollection 2026. J Inflamm Res. 2026. PMID: 42232153 Free PMC article. Review.
The neuroinflammatory mechanisms underlying Parkinson's disease (PD) have evolved from a view of localized central events to a systemic network perspective involving "brain-periphery" interactions. ...Second, it transcends central nervous system limitations t …
The neuroinflammatory mechanisms underlying Parkinson's disease (PD) have evolved from a view of localized central even …
The gut-brain axis in Alzheimer's and Parkinson's diseases: a systematic review of microbiota-derived biomarkers and novel therapeutic approaches.
Singh VK, Gupta P, Jain SK, Matreja PS. Singh VK, et al. J Clin Exp Neuropsychol. 2026 Jun 2:1-16. doi: 10.1080/13803395.2026.2673084. Online ahead of print. J Clin Exp Neuropsychol. 2026. PMID: 42227044 Review.
BACKGROUND: The altered gut microbiota substantially impacts the onset and progression of Alzheimer's disease (AD) and Parkinson's disease (PD), the two most widely studied neurodegenerative conditions. Microbiome-derived metabolites have …
BACKGROUND: The altered gut microbiota substantially impacts the onset and progression of Alzheimer's disease (AD) and Park …
2,308 results